Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

565 Articles

Chris Lange | Dec 26, 2019 at 8:55 AM EST

Big Pharma Short Sellers Get Selective

The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | Dec 24, 2019 at 7:55 AM EST

Allergan Gets FDA Approval for Migraine Treatment

The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain…

Chris Lange | Dec 11, 2019 at 9:45 AM EST

Big Pharma Short Sellers Grow More Selective

The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Nov 27, 2019 at 9:00 AM EST

Big Pharma Short Sellers Hike Their Bets

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 19, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack…

Trey Thoelcke | Nov 18, 2019 at 7:45 AM EST

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Here are five health-care-related stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross.

Chris Lange | Nov 12, 2019 at 8:50 AM EST

Big Pharma Scares Off Short Sellers

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 27, 2019 at 6:55 AM EDT

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

24/7 Wall St. has put together a preview of AT&T, Facebook, T-Mobile and the other most prominent earnings reports due…

Chris Lange | Oct 25, 2019 at 9:59 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Oct 15, 2019 at 6:35 AM EDT

20 Dividend Stocks for All Baby Boomers to Retire On

Here are 20 companies that should offer investors who are retired or near retirement some added income to help make…

Chris Lange | Oct 14, 2019 at 10:05 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan has finally announced that its shareholders have voted to approve the company’s acquisition of AbbVie. The acquisition is expected…

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 28, 2019 at 9:10 AM EDT

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

The week of September 28 saw many analyst upgrades and positive calls in blue-chip stocks. Here are six that received…

Lee Jackson | Sep 27, 2019 at 10:45 AM EDT

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter…

Lee Jackson | Sep 26, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk and…

1 … 13 14 15 16 17 … 38

AbbVie : ABBV

All AbbVie Articles

Big Pharma Short Sellers Get Selective

Allergan Gets FDA Approval for Migraine Treatment

Big Pharma Short Sellers Grow More Selective

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Big Pharma Scares Off Short Sellers

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

Short Sellers Can’t Make Up Their Minds on Big Pharma

20 Dividend Stocks for All Baby Boomers to Retire On

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees Rising Tide in Short Interest

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

AbbVie : ABBV

All AbbVie Articles

Big Pharma Short Sellers Get Selective

Allergan Gets FDA Approval for Migraine Treatment

Big Pharma Short Sellers Grow More Selective

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Big Pharma Scares Off Short Sellers

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

Short Sellers Can’t Make Up Their Minds on Big Pharma

20 Dividend Stocks for All Baby Boomers to Retire On

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees Rising Tide in Short Interest

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do